MyAverix Finance
US · Healthcare
Supernus Pharmaceuticals Inc (SUPN)
Drug Manufacturers - Specialty & Generic
Supernus Pharmaceuticals Inc (SUPN) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SUPN
Supernus Pharmaceuticals Inc (SUPN) — FAQ
What is SUPN's P/E ratio?
The price-to-earnings (P/E) ratio for Supernus Pharmaceuticals Inc (SUPN) is 18.00 (data as of 2026-03-24).
Does Supernus Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Supernus Pharmaceuticals Inc (SUPN). Check the MyAverix Finance app for the latest dividend data.
What sector is Supernus Pharmaceuticals Inc in?
Supernus Pharmaceuticals Inc (SUPN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is SUPN listed on?
SUPN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.